The document provides details on Master Formula Records (MFRs), including that MFRs:
- Are master documents that contain all information about manufacturing a pharmaceutical product, including ingredients, quantities, processes, and quality checks.
- Are prepared by the research and development team and used as a reference for batch manufacturing.
- Include product details, manufacturing processes, packaging processes, calculations, and quality approval by production and quality assurance heads.
MFRs ensure consistency in production and provide standards for Batch Manufacturing Records. Comprehensive information in MFRs allows for accurate reproduction of manufacturing batches.
Master Formula Record (MFR) is a master document for any
pharmaceutical product. MFR contains all information about the manufacturing process
for the product. MFR is prepared by the research and development team of the
company. MFR is used as reference standard for preparing batch manufacturing record (BMR) by manufacturing units.
Master Formula Record (MFR) is a master document for any
pharmaceutical product. MFR contains all information about the manufacturing process
for the product. MFR is prepared by the research and development team of the
company. MFR is used as reference standard for preparing batch manufacturing record (BMR) by manufacturing units.
A Study on Documentation Maintenance in the Pharmaceutical Industry which includes the main records to be maintained and the quality attributes to be studied about the Quality Management System. Quality attributes include the study of quality audit, quality review, and quality documentation.
A Study on Documentation Maintenance in the Pharmaceutical Industry which includes the main records to be maintained and the quality attributes to be studied about the Quality Management System. Quality attributes include the study of quality audit, quality review, and quality documentation.
Documentation in pharmaceutical industryPooja Harkal
It's all about the topic of documentation in pharmaceutical industry. In this the specifications of pharmaceutical quality assurance plays the main role so that it's mainly effective for the people who is in the stream of pharmaceutical quality assurance.
Documentation in pharaceutical industryJayeshRajput7
documentation in pharmaceutical industry, master formula record (MFR), DMF (drug master file), distribution records, generic drugs product development, hatch waxman act, CFR (code of federal regulation), drug product performance, in vitro ANDA regulatory approval process, NDA approval process, BE and drug product assessment, in-vivo scale up process approval changes, post marketing surveillance, outsourcing BA and BE to CRO (contract research organisation), Regulatory requireents for product approval, API, Biologics, Novel therapies obtaining NDA, ANDA for generic drug ways and means of US registration for foreign drugs.
Documentation control - principles of GMPAJAYKUMAR4872
Documentation is an essential part of QA and relates to all aspects of GMP.
The pharmaceutical industry must have a good document framework (infrastructure).
It is important for a manufacturer to get the documentation right in order to get the product right.
Unit 4 Document maintenance in Pharmaceutical Industry.pptxAshwiniBhoir2
Document maintenance in pharmaceutical industry: Batch Formula Record, Master Formula
Record, SOP, Quality audit, Quality Review and Quality documentation, Reports and
documents, distribution records.
pratik ghive cGMP According to schedule Mpratikghive82
Pratik Ghive Current Good Manufacturing Practices (cGMP) Guidelines According to schedule M Cover all guidelines as per Drug and cosmetic act 1940 and ICH guidelines
Safalta Digital marketing institute in Noida, provide complete applications that encompass a huge range of virtual advertising and marketing additives, which includes search engine optimization, virtual communication advertising, pay-per-click on marketing, content material advertising, internet analytics, and greater. These university courses are designed for students who possess a comprehensive understanding of virtual marketing strategies and attributes.Safalta Digital Marketing Institute in Noida is a first choice for young individuals or students who are looking to start their careers in the field of digital advertising. The institute gives specialized courses designed and certification.
for beginners, providing thorough training in areas such as SEO, digital communication marketing, and PPC training in Noida. After finishing the program, students receive the certifications recognised by top different universitie, setting a strong foundation for a successful career in digital marketing.
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdfTechSoup
In this webinar you will learn how your organization can access TechSoup's wide variety of product discount and donation programs. From hardware to software, we'll give you a tour of the tools available to help your nonprofit with productivity, collaboration, financial management, donor tracking, security, and more.
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
Embracing GenAI - A Strategic ImperativePeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
Normal Labour/ Stages of Labour/ Mechanism of LabourWasim Ak
Normal labor is also termed spontaneous labor, defined as the natural physiological process through which the fetus, placenta, and membranes are expelled from the uterus through the birth canal at term (37 to 42 weeks
2. MASTER FORMULA RECORD [MFR]
Master Formula Record (MFR) is a master document for any
pharmaceutical product.
MFR contains all information about the manufacturing process
for the product.
MFR is prepared by the research and development team of the
company.
MFR is used as reference standard for preparing batch
manufacturing record (BMR) by manufacturing units.
MFR is also called Master Manufacturing Record,
Master Production Record.
3. Definition
“A document or set of documents specifying
the starting materials with their quantities
and the packaging materials, together with a
description of the procedures and precautions
required to produce a specified quantity of a
finished product as well as the processing
instructions, including the in-process
controls.”
4. Continued…
There shall be Master Formula records relating to all
manufacturing procedures for each product and batch size to be
manufactured. These shall be prepared and endorsed by the
competent technical staff i.e. head of production and quality
control.
MFR plays an important in consistency for each batch
manufacturing.
5. MFR should include -
Product Details :
• Name, logo and address of the manufacturing company.
• Dosage form name.
• Brand name.
• Generic name.
• Product code
• Label claim of all ingredients
• Product description
• Batch size
• Pack size and packing style
6. …CONTINUED
• Shelf life
• Storage conditions
• MFR number and date
• Supersede MFR number and date
• Effective batch number
• Authorization by the production and quality assurance
head
7. …CONTINUED
Flow Chart: Steps of the manufacturing process to be
monitored. Flowchart of the material movement from
dispensing to the final product to stores.
Equipment: Create a list of all required equipment and
machines required in the manufacturing process with their
capacity.
Special instructions: Write down the precautions special
instructions to follow during the product manufacturing and
packing and these should also be added in the batch
manufacturing formula.
8. …CONTINUED
Calculations: Include the calculation steps of all active
materials to get the 100% of the active material. The
calculation shall be done using water or LOD to get 100%
potency.
Manufacturing Process: Write all steps in all stages of
the manufacturing process. All process steps like shifting,
milling, lubricating, granulation, compression and coating
should be written in detail including the process time and
yield.
It also include atmospheric conditions as temperature,
humidity, and storage conditions for every step.
9. …CONTINUED
Packing Process: List of all packing materials with their
quantity is written. Line clearance, reconciliation of printed
and unprinted packing materials should be included in
details.
Yield: Include the theoretical, actual yield and acceptance
limit of the batch.
10. Procedure to prepare a Master Formula
Record:
A Master Formula Record is either prepared based upon
experience of competent qualified staff
like manufacturing chemist or analytical chemist or
prepared based upon batch manufacturing record of a
batch size.
Once Master Formula Record is prepared, it is
transferred to previous staff to new staff. It is followed
as standard documents for processing a batch.
Master Formula record is consider as standard for making
a Batch Manufacturing Record.
11. SOP for preparation of the Master
Formula Record:
RESPONSIBLE DEPARTMENTS:
Primary Responsibility:
F&D and Production Department
Secondary Responsibility:
Quality Assurance Department
ACCOUNTABILITY:
Head-Quality Assurance shall be responsible for
implementation of SOP
.
12. STEPS TO PREPARE A MASTER FORMULA
RECORD:
Production Department in association with F&D, shall
prepare MFR.
MFR shall prepared as per the format attached with this
SOP
.
MFR shall be divided into two parts:
Packaging part
Manufacturing part
13. The first page of both the sections shall have
following details:
Name, address and logo of the company
Dosage form
Brand name
Generic name
Product code
Label claim : this should include all ingredients and
text included in product permission
14. Product Description
Batch Size
Pack Size
Shelf Life
Storage conditions
Drug Schedule: whether schedule H or schedule G drug.
Superseded Master card number and Date.
Present Master card number and Date.
Present Master card effective Batch number.
Reference of changed control number.
There shall be authorization of Master Formula Record by all
the responsible members
15. The secondary page of manufacturing section shall
include-Process steps to be monitored.
Subsequent pages shall include the processes to be
monitored. The stage wise movement of material in a
form of flow chart.
The list of equipment, machines ,utensils to be used, shall
be described.
The subsequent page shall include any special precautions
to be taken for the product during manufacturing and
packing. The same page should also include Batch
Manufacturing Formula.
16. Batch Formula should have the following columns:
Serial number
Name of ingredients
Reference of specifications of ingredients
Quantity to be added (in mg/ml or per tablet or per
capsule or per gm. as the case may be)
Overages to be added(in %)
Quantity to be added per batch or per lot
Below that give the calculation step for every active
material, ensuring that the active material shall be
compensated for assay values less than 100% which could be
due to less potency or higher moisture content.
17. • At the end of every important stage, include a statement of
the yield with the acceptable limits.
• Include in-process quality checks during and at the end of
important steps and stages with their limits.
• The process shall include the process equipment to be used.
The methods or the reference of the methods/procedures to
employed for preparing, cleaning, assembling,operating the
various equipments shall be given.
• Include detailed stepwise processing instructions(example:
checks on materials, pretreatments, sequence for adding
materials, mixing times, temperatures, humidity etc.)
• Includes the requirements for storage conditions of the
products.
18. • The packaging part of MFR should include complete list of all the
packaging materials required for a standard batch size,including
quantities,sizes and types.
• Include line clearance checking during batch cording and batch
packaging operations.
• Includes reconciliation of printed and unprinted packaging
materials with acceptable limits.
• Includes destruction of excess or rejected printed packaging
materials
• Includes description of packaging operation including any significant
subsidiary operations and equipments to be used.
19.
20. MASTER FORMULA RECORDS
Master formula records are defined as written procedure that give the complete
description of all aspects of its manufacture, packing and control with an infection to ensure
the purity, identify, quality and strength of each dosage unit through its shelf life.
It includes the following information,
Specifying a fixed formulation
Identifying quality criteria for components
Providing a set of manufacturing instruction in clear terms
Describing systematic sampling procedures
Listing precise assays, tests etc.
Establishing methods for ensuring complete accountability for all materials Including
packing and labelling.
7
21. Types of Master Formula Records
The master formula records give proportion of ingredients in
the formulation.
Master batch formula records, which specify absolute amounts
of specific potent ingredients and excipients.
8
22. MASTER PRODUCTION AND CONTROL RECORDS
Master production and control records are defined as detailed
written instructions including all operations starting from dispensing of
raw materials till finishing of bulk products and packaging operation of
a particular product.
Master production and control record includes batch size, date
of manufacture and full signature (hand written) by one person and
further independently checked, dated and signed by second person.
9
25. BATCH PRODUCTION AND CONTROL RECORDS
12
Batch production and control records shall be prepared for each batch
of drug product produced and shall include complete information relating to
the production and control of each batch.
These records shall include:
(a) An accurate reproduction of the appropriate master
production or control record, checked for accuracy, dated, and signed;
(b) Documentation that each significant step in the manufacture,
processing, packing, or holding of the batch was accomplished.
26. 13
Dates;
Identity of individual major equipment and lines used;
Specific identification of each batch of component or in-process material used; Weights and
measures of components used in the course of processing;
In-process and laboratory control results;
Inspection of the packaging and labeling area before and after use;
A statement of the actual yield and a statement of the percentage of theoretical yield at appropriate
phases of processing;
Complete labeling control records, including specimens or copies of all labeling used; Description of
drug product containers and closures;
Any sampling performed;
Identification of the persons performing and directly supervising or checking each significant step in
the operation;
Any investigation made according to.
Results of examinations made in accordance with.
BATCH PRODUCTION AND CONTROL RECORDS